Cardiovascular Disease Literature

A sedentary lifestyle, alcohol, and cigarette consumption increase body weight which in turn hinders healthy blood circulation and strength of arteries and veins. This results in high blood pressure. So, if you’re overweight, you need to monitor your blood pressure frequently. Constant high levels of stress can disturb the blood flow and blood pressure and can damage vessels, and you may experience dizziness, extreme fatigue, or body aches with no wish to get out of bed. This stress-induced fatigue can make your blood pressure high and needs to be monitored.

Literature review: Cardiovascular Disorders: A Review Of The Literature Cardiovascular diseases (CVD) are one of the leading causes of death worldwide and represent a major challenge for the health system. This Literature review deals with the current scientific knowledge to disease risk factors, diagnostic methods and treatment strategies for cardiovascular disease. Risk factors and epidemiology According to the results of several epidemiological studies of modifiable and non-modifiable risk factors play a crucial role in the pathogenesis of CVD. Among the most important modifiable factors: Hypertension (blood pressure≥140/90 mmHg), Hyperlipidemia (elevated concentration of LDL‑cholesterol), Diabetes mellitus type 2, Smoking Overweight and obesity (BMI ≥30 kg/m 2 ), physical inactivity, unhealthy diet. Non-modifiable factors include age, gender (men are at the age of 65. Age at greater risk), and family history of early cardiovascular events. A study by the World Health Organization (WHO, 2023) estimates that more than 17 million deaths each year are due to cardiovascular disease, which accounts for about 30% of all Global deaths. Diagnostic Procedures The modern diagnosis of CVD is based on a combination of different methods: History and physical examination: evaluation of risk factors, symptoms, and cardiovascular signs. Laboratory analyses: measurement of lipid profiles, blood sugar, kidney values and specific biomarkers such as Troponin and NT‑proBNP. Electrocardiogram (ECG): for the detection of arrhythmias, signs of ischemia or infarction follow. Echocardiography: imaging method for the assessment of cardiac structure and function. Load tests (e.g., treadmill test): for the functional assessment under load. Coronary angiography: invasive method for direct visualization of narrowings in the coronary arteries. Therapeutic Approaches The treatment of CVD includes pharmacological and interventional measures: Drugs: Antihypertensive (ACE inhibitors, beta-blockers), Lipid-Lowering Drugs (Statins), Antidiabetic agents Platelet aggregation inhibitors (e.g., acetylsalicylic acid). Interventional Procedures: Percutaneous coronary Intervention (PCI) with stent implantation, Coronary bypass surgery (CABG). Life style modifications: Smoking abstinence a healthy diet (e.g., DASH diet), regular physical activity (at least 150 minutes of moderate load per week), Weight control. Current Research Trends Recent studies focus on the development of more precise risk stratification methods, the use of Artificial intelligence for the analysis of ECG data, as well as the study of genetic and epigenetic factors in CVD. In addition, new drugs, such as PCSK9 inhibitors for aggressive LDL reduction are investigated intensively. Conclusion Scientific progress has led to significant improvements in the prevention, diagnosis and therapy of cardiovascular diseases. Nevertheless, the reduction of risk factors and the promotion of a healthy life style the most important measure to reduce the morbidity and mortality due to CVD. Further research is necessary to optimize individual treatment approaches and to improve the quality of life in a sustainable way. Sources (Examples) WHO (2023): Global Health Estimates. German heart Foundation (2022): guidelines for the prevention of cardiovascular diseases. European Society of Cardiology (2021): Guidelines on cardiovascular disease prevention.

Leaves of the Banaba tree, also known as Crape Myrtle, offer multiple medicinal properties. Scientific studies and research found that it can lower triglyceride levels by 35% and increases good cholesterol level (HDL) by 14%. Not just that, the studies have also shown positive outcomes in cardiovascular diseases, diabetes, and blood pressure. It also has antioxidant properties and helps manage and control weight which ultimately causes the surge in blood flow pressure. Cardio Balance helps reduce blood fat levels by reducing the production of cholesterol and triglycerides in the body and improving the transportation of fats in the bloodstream.

With Cardio Balance supplement, you can enjoy the peace of mind that comes with taking control of your cardiovascular health. All the natural ingredients are expertly combined in the right dosages to support all your organs, ensuring they receive the necessary nutrients to function optimally. This all-natural solution helps regulate blood pressure and cholesterol levels without the fear of adverse side effects, empowering you to live your best life.
Cardiovascular Disease Literature

Ang presyon ng dugo ay isa sa mga pangunahing indikasyon ng kalusugan, na hindi lamang sumasalamin sa puso at sistema ng sirkulasyon, kundi pati na rin sa aktibidad ng mga bato, mga organo ng endokrin, paggawa ng dugo, at ng sistema ng nerbiyos. Kaya naman, walang isang unibersal na gamot laban sa mataas na presyon ng dugo. Hindi ka basta basta puwedeng pumunta sa botika at magtanong ng 'tableta para sa presyon,' kasi agad na tatanungin ng parmasyutiko – anong gamot ang nireseta sa iyo ng doktor?

Punan ang form ng konsultasyon at order Cardiovascular Disease Literature. Lilinawin ng operator ang lahat ng detalye sa iyo at ipapadala namin ang iyong order.

Cardiovascular Disease Literature. The Problem of the disease of the cardiovascular System.

I am happy to offer a scientific Text on the topic of cough as a side effect of high blood pressure tablets in German: Cough as a side effect when taking antihypertensive therapy: pathophysiology and clinical relevance Cough is a relatively common side effect in the treatment of arterial hypertension, in particular in connection with the use of certain anti-hypertensive drugs. This article examines the relationships between the use of Hypertension drugs, and the Occurrence of a chronic cough, sheds light on the possible pathophysiological mechanisms, and discusses diagnostic and therapeutic strategies. Prevalence and relevant substance classes A drug-induced cough occurs mainly in the treatment with ACE inhibitors (Angiotensin‑converting enzyme inhibitors). This group includes agents such as Enalapril, Ramipril and Lisinopril. According to studies, approximately 5-20% of patients on ACE inhibitors develop a dry, irritating cough. Less often, a cough with other anti-hypertensive substances is brought in connection with this, including beta-blockers or calcium channel blockers, however, the Evidence here is much weaker. Pathophysiological Mechanisms The cough with ACE inhibitors is mainly attributed to an accumulation of Bradykinin and other peptides (e.g. substance P) back. ACE inhibitors not only inhibit the conversion of Angiotensin I to Angiotensin II, but also the degradation of Bradykinin. Increased bradykinin concentration in the tissues of the respiratory tract fibers to irritation of the sensory nerves and lead to a chronic, dry cough. Other possible mechanisms include: an increased production of prostaglandins and Leukotrienes; a local inflammatory response in the respiratory tract; a change in the sensitivity of the cough receptors. Clinical Features The typical ACE‑inhibitor‑associated cough has the following characteristics: dry, non-productive cough; Onset usually within the first weeks to months after initiation of therapy; the lack of signs of a respiratory infection or other lung diseases; Regression of the cough within 1-4 weeks after Discontinuation of the drug. Diagnostics The hand for a suspicious cough after taking a high blood pressure should include the following steps: Medical history: Temporal relationship between drug intake and cough at the beginning, to the exclusion of other possible causes (e.g., Asthma, GERA Reflux, infections). Physical examination and, if necessary, chest x‑ray, organic diseases of the lung to exclude. A therapeutic trial discontinuation of the ACE Inhibitor for 2-4 weeks for the Review of an improvement. If necessary: change to an AT1‑receptor blocker (so-called Sartans, such as Losartan, Valsartan), which do not cough. Therapeutic Options The cough should affect the patients ' quality of life significantly, has the following actions available: The ACE Inhibitor and exchange discontinuation of other antihypertensive drug (for example, a Sartan, a calcium channel blocker or a beta-blocker). In the case of persistent cough even after Discontinuation: further investigation to the exclusion of the diagnosis of other cough causes. Supportive measures such as cough-relieving agent (with caution, since this does not relieve the respiratory tract) or local treatments in case of irritation of the mucous membranes. Conclusion Cough as a side effect of high blood pressure tablets, in particular, ACE inhibitors, is a well-known and pathophysiologically natural phenomenon. The early detection and, where appropriate, the exchange on alternative medicines allow for the effective treatment of arterial hypertension without affecting the quality of life of chronic cough. An individual risk‑Benefit assessment, and close patient education is of Central importance. If you want, I can make certain sections in more detail or other sources and study information to add!